Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

Mesenchymal stem/stromal cell-based therapies for autism spectrum disorder: emerging evidence and clinical prospects.
(2026 Mar 20)
J Transl Med
Xu M, Zhang X, Liu Y, Yang Y, Zhou Z, Ma J, Shen S

Open and sustainable AI: challenges, opportunities and the road ahead in the life sciences.
(2026 Mar 20)
Nat Methods
Farrell G, Adamidi E, Andrade Buono R, Anton M, Attafi OA, Capella Gutierrez S, Capriotti E, Castro LJ, Cirillo D, Crossman L, Dessimoz C, Dimopoulos A, Fernández-Díaz R, Fragkouli SC, Goble C, Gu W, Hancock JM, Khanteymoori A, Lenaerts T, Liberante FG, Maccallum P, Monzon AM, Palmblad M, Poveda L, Radulescu O, Shields DC, Sufi S, Vergoulis T, Psomopoulos F, Tosatto SCE

Construct validity of real-world digital mobility outcomes in patients after proximal femoral fracture: a cross-sectional observational study.
(2026 Mar 20)
Sci Rep 16(1):
Eckert T, Berge MA, Long M, de Las Heras M, Alvarez P, Blain H, Braun J, Buekers J, Caulfield B, Engdal M, Frei A, Helbostad JL, Ionescu A, Jansen CP, Johnsen LG, Klenk J, Koch S, Lanfranchi V, Rochester L, Becker C, Vereijken B, Garcia-Aymerich J

Changes to serum lipids, BMI and body composition in adults with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor (ETI): A scoping review.
(2026 Mar 20)
J Cyst Fibros
Walsh A, Landers C, Lucey N, Griffin O, Carter S, Corish CA

Infectious complications of burns in the intensive care unit.
(2026 Mar 19)
J Crit Care 94(): 155519
Fennessy A, Slattery L, Shelley O, Reyes LF, Martin-Loeches I

Show complete publication list

In the News